"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 5 | 5 |
| 1995 | 0 | 16 | 16 |
| 1996 | 0 | 26 | 26 |
| 1997 | 1 | 32 | 33 |
| 1998 | 0 | 41 | 41 |
| 1999 | 0 | 45 | 45 |
| 2000 | 1 | 44 | 45 |
| 2001 | 0 | 52 | 52 |
| 2002 | 0 | 47 | 47 |
| 2003 | 0 | 126 | 126 |
| 2004 | 0 | 105 | 105 |
| 2005 | 0 | 111 | 111 |
| 2006 | 0 | 138 | 138 |
| 2007 | 0 | 154 | 154 |
| 2008 | 0 | 140 | 140 |
| 2009 | 4 | 134 | 138 |
| 2010 | 10 | 155 | 165 |
| 2011 | 16 | 163 | 179 |
| 2012 | 8 | 151 | 159 |
| 2013 | 6 | 173 | 179 |
| 2014 | 14 | 168 | 182 |
| 2015 | 13 | 196 | 209 |
| 2016 | 9 | 137 | 146 |
| 2017 | 11 | 199 | 210 |
| 2018 | 13 | 178 | 191 |
| 2019 | 14 | 181 | 195 |
| 2020 | 9 | 150 | 159 |
| 2021 | 8 | 122 | 130 |
| 2022 | 2 | 57 | 59 |
| 2023 | 0 | 60 | 60 |
| 2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection. Genome Med. 2024 Feb 05; 16(1):24.
-
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2024 May; 31(5):3314-3324.
-
Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals. Front Immunol. 2024; 15:1348041.
-
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer. Clin Cancer Res. 2024 01 17; 30(2):334-343.
-
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET. Trials. 2024 Jan 16; 25(1):58.
-
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study. Nat Commun. 2024 Jan 03; 15(1):216.
-
Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal Aberrations: A Case Report and Literature Review. Genes (Basel). 2023 Dec 08; 14(12).
-
Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell. 2023 12 07; 186(25):5620-5637.e16.
-
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2. Ann Oncol. 2023 12; 34(12):1131-1140.
-
Long-term non-progression and risk factors for disease progression among children living with HIV in Botswana and Uganda: A retrospective cohort study. Int J Infect Dis. 2024 Feb; 139:132-140.